Use of cyclopamine in the treatment of psoriasis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4355 (2006.01) A61K 8/63 (2006.01) A61P 17/06 (2006.01) A61Q 19/00 (2006.01)

Patent

CA 2452152

This invention relates to the use of cyclopamine in the treatment of psoriasis and achievement of rapid clearance of the psoriatic lesions from the skin of patients with no detectable side effects. Disappearances of the clinical signs of psoriasis, including the erythema and scaling, from the skin of patients are accompanied by the reversions of histopathological signs to normalcy and are achievable by topical treatment as fast as within a day. These features make the use of cyclopamine highly desirable in the treatment of psoriasis.

L'invention concerne l'utilisation de la cyclopamine dans le traitement du psoriasis et la réalisation de la disparition rapide de lésions psoriasiques de la peau des patients, sans effet secondaire détectable. La disparition des signes cliniques du psoriasis, y compris l'érythème et la desquamation, de la peau des patients est accompagnée du retour à la normale des signes histopathologiques, et peut être obtenue par traitement local en moins d'une journée. Ces caractéristiques rendent très souhaitable l'utilisation de la cyclopamine dans le traitement du psoriasis.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of cyclopamine in the treatment of psoriasis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of cyclopamine in the treatment of psoriasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of cyclopamine in the treatment of psoriasis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1527707

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.